Tags

Type your tag names separated by a space and hit enter

Use of antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia in the indirect hemagglutination assay for melioidosis.
Clin Vaccine Immunol. 2007 Nov; 14(11):1529-31.CV

Abstract

The serological diagnosis of melioidosis is carried out using the indirect hemagglutination assay. We looked at the reactivity of sera from culture-proven cases of melioidosis from north Queensland against antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia. Cross-reactivity between sera from culture-positive cases of melioidosis and B. thailandensis was demonstrated.

Links

Publisher Full Text
ncbi.nlm.nih.gov
cvi.asm.org
PMC Free PDF

Authors+Show Affiliations

Gilmore G
Queensland Health Pathology Services, Townsville Hospital, Townsville, Australia, 4814.
Barnes J
No affiliation info available
Ketheesan N
No affiliation info available
Norton R
No affiliation info available

MeSH

Antibodies, BacterialAntigens, BacterialBurkholderiaBurkholderia InfectionsBurkholderia cepaciaBurkholderia pseudomalleiHemagglutination TestsHumansMelioidosisQueensland

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17804613

Citation

Gilmore, Glenda, et al. "Use of Antigens Derived From Burkholderia Pseudomallei, B. Thailandensis, and B. Cepacia in the Indirect Hemagglutination Assay for Melioidosis." Clinical and Vaccine Immunology : CVI, vol. 14, no. 11, 2007, pp. 1529-31.
Gilmore G, Barnes J, Ketheesan N, et al. Use of antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia in the indirect hemagglutination assay for melioidosis. Clin Vaccine Immunol. 2007;14(11):1529-31.
Gilmore, G., Barnes, J., Ketheesan, N., & Norton, R. (2007). Use of antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia in the indirect hemagglutination assay for melioidosis. Clinical and Vaccine Immunology : CVI, 14(11), 1529-31.
Gilmore G, et al. Use of Antigens Derived From Burkholderia Pseudomallei, B. Thailandensis, and B. Cepacia in the Indirect Hemagglutination Assay for Melioidosis. Clin Vaccine Immunol. 2007;14(11):1529-31. PubMed PMID: 17804613.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Use of antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia in the indirect hemagglutination assay for melioidosis. AU - Gilmore,Glenda, AU - Barnes,Jodie, AU - Ketheesan,Natkunam, AU - Norton,Robert, Y1 - 2007/09/05/ PY - 2007/9/7/pubmed PY - 2008/1/15/medline PY - 2007/9/7/entrez SP - 1529 EP - 31 JF - Clinical and vaccine immunology : CVI JO - Clin Vaccine Immunol VL - 14 IS - 11 N2 - The serological diagnosis of melioidosis is carried out using the indirect hemagglutination assay. We looked at the reactivity of sera from culture-proven cases of melioidosis from north Queensland against antigens derived from Burkholderia pseudomallei, B. thailandensis, and B. cepacia. Cross-reactivity between sera from culture-positive cases of melioidosis and B. thailandensis was demonstrated. SN - 1556-6811 UR - https://www.unboundmedicine.com/medline/citation/17804613/Use_of_antigens_derived_from_Burkholderia_pseudomallei_B__thailandensis_and_B__cepacia_in_the_indirect_hemagglutination_assay_for_melioidosis_ L2 - http://cvi.asm.org/cgi/pmidlookup?view=long&pmid=17804613 DB - PRIME DP - Unbound Medicine ER -